Serum uric acid levels are associated with polymorphism in the SAA1 gene in Chinese subjects

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Xie, Xiang ^a,b   Ma, Yi Tong ^a,b   Yang, Yi Ning ^a,b   Li, Xiao Mei ^a,b   Fu, Zhen Yan ^a,b   Zheng, Ying Ying ^a,b   Ma, Xiang ^a,b   Chen, Bang Dang ^b   Liu, Fen ^b   Huang, Ying ^a,b   Yu, Zi Xiang ^a,b   Chen, You ^a,b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Xinjiang Key Laboratory of Cardiovascular Disease Research   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID; SAA1 PROTEIN, HUMAN; SERUM AMYLOID A;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAA1 GENE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; URIC ACID BLOOD LEVEL; ASIAN; BLOOD; CHINA; DEMOGRAPHY; EPIDEMIOLOGY; ETHNIC GROUP; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEMOGRAPHY; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SERUM AMYLOID A PROTEIN; URIC ACID;

EID: 84863100838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040263     Document Type: Article

References (31)

1. Shi Y, Evans JE, Rock KL, (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
2. Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, et al. (1998) Uric acid in chronic heart failure: A marker of chronic inflammation. European Heart Journal 19: 1814-1822.
3. Shi Y, (2010) Caught red-handed: uric acid is an agent of inflammation. J Clin Invest 120: 1809-1811.
4. Alper AB, Chen W, Yau L, Srinivasan SR, Berenson GS, et al. (2005) Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 45: 34-38.
5. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, et al. (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183-1190.
6. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, et al. (1996) Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20: 975-980.
7. Ogura T, Matsuura K, Matsumoto Y, Mimura Y, Kishida M, et al. (2002) Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through. Metabolism 2004 53: 448-453.
8. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, et al. (2003) Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 18: 523-530.
9. Alderman MH, Cohen H, Madhavan S, Kivlighn S, (1999) Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 34: 144-150.
10. Manzato E, (2007) Uric acid: an old actor for a new role. Intern Emerg Med 2: 1-2.
11. Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, et al. (2007) Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women. Intern Emerg Med 2: 19-23.
12. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J, (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
13. Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J, (2005) A unifying pathway for essential hypertension. Am J Hypertens 18: 431-440.
14. Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H, (1993) The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheumatol 32: 729-33.
15. Xie X, Ma YT, Yang YN, Fu ZY, Li XM, et al. (2010) Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the Cardiovascular Risk Survey. PLoS One 5(11): e13997.
16. Xie X, Ma YT, Yang YN, Fu ZY, Li XM, et al. (2010) Association of genetic polymorphisms of serum amyloid protein A1 with plasma high density lipoproteins cholesterol. Zhonghua Yi Xue Za Zhi. 90: 1824-6.
17. Xie X, Ma YT, Yang YN, Fu ZY, Li XM, et al. (2011) Polymorphisms in the SAA1 gene are associated with ankle-to-brachial index in Han Chinese healthy subjects. Blood Press 20(4): 232-8.
18. Patel S, Flyvbjerg A, Koza'kova' M, Frystyk J, Ibrahim IM, et al. (2008) Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J 29: 386-393.
19. Xie X, Ma YT, Fu ZY, Yang YN, Ma X, et al. (2009) Haplotype Analysis of the CYP8A1 gene associated with myocardial infarction. Clin Appl Thromb-Hem 15: 574-580.
20. Xie X, Ma YT, Fu ZY, Yang YN, Ma X, et al. (2009) Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction. Clin Chem Lab Med 47: 347-352.
21. Gabay C, Kushner I, (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 340: 448-454.
22. Uhlar CM, Whitehead AS, (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265: 501-523.
23. van der Harst P, Bakker SJL, de Boer R, Wolffenbuttel BHR, Johnson T, et al. (2010) Replication of the five novel loci for uric acid concentrates and potential mediating mechanisms. Human Molecular Genetics 19: 387-395.
24. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, et al. (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5(6): e1000504.
25. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, et al. (2008) Genome-wide association study identifies genes for biomarkers of cardiovascular disease: Serum urate and dyslipidemia. The American Journal of Human genetics 82: 139-149.
26. Caulfield MJ, Munroe PB, O'Neill D, Witkowska K, Charchar FJ, et al. (2008) SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 5(10): e197.
27. Benditt EP, Eriksen N, Hermodson MA, Ericsson LH, (1971) The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences. FEBS Lett 19: 169-173.
28. Levin M, Franklin EC, Frangione B, Pras M, (1972) The amino acid sequence of a major nonimmunoglobulin component of some amyloid fi brils. J Clin Invest 51: 2773-2776.
29. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, et al. (2006) Uric acid and inflammatory markers. Eur Heart J. 2006 27: 1174-81.
30. Yamada T, Wada A, Itoh Y, Itoh K, (1999) Serum amyloid A1 alleles and plasma SAA concentration. Amyloid 6: 199-204.
31. Kang DH, Park SK, Lee IK, (2005) Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16: 3553-3562.